Fundz

Spotlight Therapeutics Raises $36.5 Million Series B To Advance A Pipeline Of Cell-Targeted In Vivo Crispr Gene Editing Biologics

PRIVATEMar 22, 2022

Amount Raised

$36.5 Million

Round Type

Series B

HaywardBiotechnologyHealthcare

Description

Spotlight Therapeutics, Inc. (“Spotlight”), a biotechnology company applying new insights to develop cell-targeted in vivo CRISPR gene editing biologics, today announced a $36.5M Series B financing to fuel a drive toward the clinic.

Who to call at Spotlight Therapeutics, Inc., and when

A new round usually means Spotlight Therapeutics, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Spotlight Therapeutics, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Spotlight Therapeutics, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Spotlight Therapeutics, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Spotlight Therapeutics, Inc.

Location

26118 Research Place

Hayward, California, United States

About

Spotlight Therapeutics develops biologics targeted to specific cell populations in gene editing.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Spotlight Therapeutics, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts19 people are listed at Spotlight Therapeutics, I…. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Spotlight Therapeutics, Inc.'s next move

See what Strategic adds

Funding Insights

What this usually means
Timeline to next round
Series B companies typically work for 15-20 months before raising new capital
Growth expectations
Series B companies are expected to scale rapidly and expand market reach

Spotlight Therapeutics, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.